MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Characterising Oromandibular Dystonia in Multiple System Atrophy: A video analysis

Y. Thongchuam, P. Panyakaew, R. Bhidayasiri (Bangkok, Thailand)

Meeting: MDS Virtual Congress 2020

Abstract Number: 1099

Keywords: Dystonia: Clinical features, Multiple system atrophy(MSA): Clinical features

Category: Parkinsonism, Atypical: MSA

Objective: To characterise craniofacial manifestations in patients with MSA and explore the relationship between OMD and other related symptoms and treatment.

Background: According to the second consensus criteria, Oromandibular dystonia (OMD) is considered a supportive feature in the diagnosis of Multiple System Atrophy (MSA). However, its clinical characteristics in MSA subtypes and the association with other symptoms have never been explored.

Method: Video clips of patients with MSA were reviewed by two movement disorders experts. Craniofacial manifestations as well as dystonia in other body parts, parkinsonism and cerebellar signs were characterized and diagnosed according to their diagnostic criteria.

Results: 24 patients with clinical diagnosis of MSA (14 MSA-P, 10 MSA-C) were recruited with clinical demographics as shown in Table 1. OMD was identified in 7/24 patients of MSA (6 MSA-P, 1 MSA-C), characterised by pulling at the side of the mouth resembling ‘risus sardonicus’ where the onset of OMD was preceded by levodopa initiation in 6 of 7 cases.Parkinsonism was the present symptom in all MSA patients with OMD, compared to 53% of MSA patients without OMD (p=0.026). Patients with OMD were more likely to have upper facial dystonia (43% vs 0%, p=0.004) and dysphagia (29% vs 0%, p=0.021). However, there was no statistically significant difference on the presence of non-cranial dystonia between the two groups.

Conclusion: Our study showed that OMD was common, affecting approximately one-third of MSA patients. The onset is usually preceded by levodopa treatment in MSA patients who have predominant parkinsonism and upper facial dystonia.

Table 1

References: Marsili L et.al. Dystonia in atypical parkinsonian disorders. PRD. 2019;66:25-33. Wenning GK et.al. Multiple system atrophy: an update. Mov Disord. 2003;18 Suppl 6:S34-42. Boesch SM.et.al. Dystonia in multiple system atrophy. Journal of neurology, neurosurgery, and psychiatry. 2002;72(3):300-3.

To cite this abstract in AMA style:

Y. Thongchuam, P. Panyakaew, R. Bhidayasiri. Characterising Oromandibular Dystonia in Multiple System Atrophy: A video analysis [abstract]. Mov Disord. 2020; 35 (suppl 1). https://www.mdsabstracts.org/abstract/characterising-oromandibular-dystonia-in-multiple-system-atrophy-a-video-analysis/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2020

MDS Abstracts - https://www.mdsabstracts.org/abstract/characterising-oromandibular-dystonia-in-multiple-system-atrophy-a-video-analysis/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley